Pharco Pharmaceuticals Inc. Sustainability Profile
Pharco Pharmaceuticals Inc., a prominent player in the pharmaceutical industry, is headquartered in Egypt (EG) and operates extensively across the Middle East and North Africa. Founded in 1994, the company has established itself as a leader in the production of high-quality generic medications, catering to a diverse range of therapeutic areas including cardiology, oncology, and infectious diseases. Pharco's commitment to innovation is evident in its extensive portfolio of over 200 products, which are distinguished by their adherence to international quality standards. The company has achieved significant milestones, including numerous certifications from global health authorities, solidifying its reputation in the competitive pharmaceutical landscape. With a focus on accessibility and affordability, Pharco Pharmaceuticals continues to enhance healthcare outcomes in the regions it serves.
DitchCarbon Score
How does Pharco Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharco Pharmaceuticals Inc.'s score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharco Pharmaceuticals Inc.'s reported carbon emissions
Pharco Pharmaceuticals Inc., headquartered in Egypt (EG), currently does not have any publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Pharco Pharmaceuticals appears to be in the early stages of establishing its climate commitments and emissions reporting. Without specific emissions data or reduction initiatives, it is challenging to assess their environmental impact or progress towards sustainability goals. In the pharmaceutical industry, companies are increasingly expected to adopt robust climate strategies and disclose emissions data to align with global sustainability standards. Pharco Pharmaceuticals may benefit from developing a comprehensive climate action plan to enhance transparency and demonstrate commitment to reducing its carbon footprint in the future.
How Carbon Intensive is Pharco Pharmaceuticals Inc.'s Industry?
How Carbon Intensive is Pharco Pharmaceuticals Inc.'s Location?
Pharco Pharmaceuticals Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pharco Pharmaceuticals Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
